Grail Llc Stock Today
| GRAL Stock | 108.98 2.67 2.51% |
PerformanceFair
| Odds Of DistressLow
|
GRAIL LLC is selling for 108.98 as of the 28th of January 2026. This is a 2.51 percent increase since the beginning of the trading day. The stock's lowest day price was 102.0. GRAIL LLC has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 30th of October 2025 and ending today, the 28th of January 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 2024 | Category Healthcare | Classification Health Care |
GRAIL LLC is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 38.98 M outstanding shares of which 5.2 M shares are currently shorted by private and institutional investors with about 6.16 trading days to cover. More on GRAIL LLC
Moving against GRAIL Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
GRAIL Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Robert Ragusa | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsGRAIL LLC can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand GRAIL LLC's financial leverage. It provides some insight into what part of GRAIL LLC's total assets is financed by creditors.
| |||||
GRAIL LLC (GRAL) is traded on NASDAQ Exchange in USA and employs 1,000 people. GRAIL LLC is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.25 B. GRAIL LLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 38.98 M outstanding shares of which 5.2 M shares are currently shorted by private and institutional investors with about 6.16 trading days to cover.
GRAIL LLC generates negative cash flow from operations
Check GRAIL LLC Probability Of Bankruptcy
Ownership AllocationGRAIL LLC secures a total of 38.98 Million outstanding shares. Over half of GRAIL LLC's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GRAIL Ownership Details
GRAIL LLC Historical Income Statement
GRAIL Stock Against Markets
GRAIL LLC Corporate Management
| Trish Rowland | VP Communications | Profile | |
| Rodger Currie | VP Development | Profile | |
| Paul Ciccolella | Development Research | Profile | |
| Andrew Partridge | Chief Officer | Profile | |
| Satnam Alag | Senior Officer | Profile | |
| Aaron Freidin | Chief Officer | Profile | |
| Nathan Hunkapiller | Senior Development | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GRAIL LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy GRAIL Stock please use our How to buy in GRAIL Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GRAIL LLC. If investors know GRAIL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GRAIL LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.66) | Revenue Per Share | Quarterly Revenue Growth 0.263 | Return On Assets | Return On Equity |
The market value of GRAIL LLC is measured differently than its book value, which is the value of GRAIL that is recorded on the company's balance sheet. Investors also form their own opinion of GRAIL LLC's value that differs from its market value or its book value, called intrinsic value, which is GRAIL LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GRAIL LLC's market value can be influenced by many factors that don't directly affect GRAIL LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GRAIL LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GRAIL LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GRAIL LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.